Trial Profile
Prospective Study of Liraglutide Effect on Blood Pressure, Lipids Profile and Liver Enzymes in Arab Patients with Type 2 Diabetes Mellitus (Lead-Arab Study).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LEAD-ARAB
- 04 Aug 2015 New trial record
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.